Zuvius Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 2.00 M
as on 16-11-2024
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 10.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.27 Cr
as on 16-11-2024
- Revenue 63.69%
(FY 2023)
- Profit 297.37%
(FY 2023)
- Ebitda 22.46%
(FY 2023)
- Net Worth 40.05%
(FY 2023)
- Total Assets -1.97%
(FY 2023)
About Zuvius Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹10.50 Cr. The company has closed loans amounting to ₹11.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Shetty, Alka Chavan, and Nimish Thakkar serve as directors at the Company.
- CIN/LLPIN
U24230MH2005PTC155998
- Company No.
155998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zuvius Lifesciences Private Limited offer?
Zuvius Lifesciences Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Injectable Products, Digestive System Drugs & Medicines, Antiemetic, Anti Cancer Injection, Oral Care Products, Artificial Saliva, Anastrozole Tablets.
Who are the key members and board of directors at Zuvius Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Shetty  | Director | 13-Sep-2005 | Current |
| Nimish Thakkar | Director | 13-Sep-2005 | Current |
| Alka Chavan | Director | 13-Sep-2005 | Current |
Financial Performance of Zuvius Lifesciences.
Zuvius Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.69% increase. The company also saw a substantial improvement in profitability, with a 297.37% increase in profit. The company's net worth Soared by an impressive increase of 40.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zuvius Lifesciences?
In 2023, Zuvius Lifesciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kreative Friends Consultancy Services Private LimitedActive 12 years 1 monthShailesh Shetty is a mutual person
- Mecobots Private LimitedActive 6 years 3 months
Shailesh Shetty and Nimish Thakkar are mutual person
- Emyrus Biotech Private LimitedActive 4 years 6 days
Shailesh Shetty and Nimish Thakkar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2022 | ₹10.00 Cr | Open |
Ing Vysya Bank Limited Creation Date: 02 Jan 2009 | ₹5.00 M | Open |
Others Creation Date: 21 Aug 2020 | ₹1.15 Cr | Satisfied |
How Many Employees Work at Zuvius Lifesciences?
Zuvius Lifesciences has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zuvius Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zuvius Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
